science

New Zealand’s parliament passed legislation enabling a free-trade agreement with India, clearing the way for a deal Prime Minister Christopher Luxon has described as “once-in-a-generation.”

Big Pharma is betting on China for its next blockbuster drugs — what that shift means for patients and the future of US biotech dominance. (Source: Bloomberg)

The Lincoln Center in NYC has welcomed 600,000 new audience members in the years since the COVID-19 pandemic, offering free of low-cost performances to attract new audiences. Chief Artistic Officer Shanta Thake shares what is on schedule for the Lincoln Center's fall programming, and why she thinks

Paisley Nardini, head of investment strategy at Tema ETFs, joins Scarlet Fu and Eric Balchunas on "Bloomberg ETF IQ." They discuss Tema Trading & Prediction Markets ETF (ticker: DICE) and Tema Space Innovators ETF (ticker: NASA). (Source: Bloomberg)

The Lincoln Center in NYC has welcomed 600,000 new audience members in the years since the COVID-19 pandemic, offering free of low-cost performances to attract new audiences. Chief Artistic Officer Shanta Thake shares what is on schedule for the Lincoln Center's fall programming, and why she thinks

Donald Trump has proven himself a generational political talent — when he’s not in the Oval Office. But as if he’s Dr. Jekyll and Mr. Hyde, he transforms into an incompetent campaign doppelganger as president. Republicans are about to pay the price again.

FDA approves Telix brain cancer imaging drug Pixclara

The Trump administration’s push to bring US drug spending down is a powerful incentive for pharmaceutical companies to boost prices and reduce access elsewhere in the world, a study found.

The Bio-Pharma Industry and Society Listing Summary Please join the CSIS Global Health Policy Center on March 17, from 10:00am – 11:30am, for an exploration of how private bio-pharmaceutical firms can better support the critically important societal goals of improved affordability, access, quality,

The Bio-Pharma Industry and Society Listing Summary Please join the CSIS Global Health Policy Center on March 17, from 10:00am – 11:30am, for an exploration of how private bio-pharmaceutical firms can better support the critically important societal goals of improved affordability, access, quality,